纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | NR4A1 |
Uniprot No | P22736 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-598aa |
氨基酸序列 | MPCIQAQYGTPAPSPGPRDHLASDPLTPEFIKPTMDLASPEAAPAAPTALPSFSTFMDGYTGEFDTFLYQLPGTVQPCSSASSSASSTSSSSATSPASASFKFEDFQVYGCYPGPLSGPVDEALSSSGSDYYGSPCSAPSPSTPSFQPPQLSPWDGSFGHFSPSQTYEGLRAWTEQLPKASGPPQPPAFFSFSPPTGPSPSLAQSPLKLFPSQATHQLGEGESYSMPTAFPGLAPTSPHLEGSGILDTPVTSTKARSGAPGGSEGRCAVCGDNASCQHYGVRTCEGCKGFFKRTVQKNAKYICLANKDCPVDKRRRNRCQFCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPF |
预测分子量 | 68.2 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于NR4A1重组蛋白的3篇参考文献及其摘要概括:
---
1. **文献名称**: "NR4A1 (Nur77) regulates the transcriptional control of proinflammatory cytokines in activated macrophages"
**作者**: Hamers AAJ, et al.
**摘要**: 该研究通过重组NR4A1蛋白实验,揭示了其在巨噬细胞炎症反应中的调控作用。研究发现,NR4A1通过抑制NF-κB信号通路,减少促炎细胞因子(如TNF-α、IL-6)的表达,表明其可能作为炎症性疾病治疗的潜在靶点。
---
2. **文献名称**: "Structural basis of Nur77-dependent ligand-independent activation of the apoptotic pathway"
**作者**: Wang Z, et al.
**摘要**: 本研究解析了重组NR4A1蛋白的晶体结构,阐明了其不依赖配体的活化机制。研究显示,NR4A1通过构象变化直接与Bcl-2家族蛋白相互作用,诱导线粒体凋亡途径,为开发靶向NR4A1的抗癌药物提供了结构基础。
---
3. **文献名称**: "Recombinant NR4A1 modulates metabolic reprogramming in cancer cells via transcriptional repression of glycolysis genes"
**作者**: Lee SL, et al.
**摘要**: 利用重组NR4A1蛋白进行功能实验,发现其通过抑制糖酵解关键基因(如HK2、LDHA)的转录,阻碍肿瘤细胞的代谢重编程,进而抑制癌细胞增殖和转移,提示NR4A1在癌症代谢治疗中的应用潜力。
---
**备注**:以上文献信息为示例性质,实际引用时建议通过PubMed或Web of Science核实具体文献。如需补充实验方法类文献,可进一步筛选涉及NR4A1重组蛋白表达与纯化技术的文章。
**Background of NR4A1 Recombinant Protein**
NR4A1 (Nuclear Receptor Subfamily 4 Group A Member 1), also known as Nur77 or TR3. is a member of the NR4A family of ligand-independent transcription factors. It functions as an early-response gene product regulated by diverse stimuli, including stress, cytokines, growth factors, and metabolic signals. Structurally, NR4A1 contains a conserved DNA-binding domain (DBD) and a ligand-binding domain (LBD), though it lacks a classical ligand-binding pocket, operating instead through constitutive activation or post-translational modifications like phosphorylation.
NR4A1 plays critical roles in cellular processes such as apoptosis, inflammation, metabolism, and cancer progression. It exhibits context-dependent functions: in immune cells, it suppresses pro-inflammatory responses and promotes macrophage polarization, while in cancer, it can act as a tumor suppressor by inducing apoptosis or as an oncogene by enhancing survival pathways. Its dual role in metabolism includes regulating glucose homeostasis and lipid metabolism, linking it to metabolic disorders like diabetes and atherosclerosis.
Recombinant NR4A1 protein is engineered for in vitro studies to dissect its molecular mechanisms. Produced using expression systems like *E. coli* or mammalian cells, the purified protein retains functional domains for DNA binding and protein-protein interactions. Researchers utilize it to study NR4A1’s transcriptional activity, interactions with co-regulators (e.g., retinoid X receptor), and its role in signaling pathways (e.g., NF-κB or MAPK). Additionally, it aids in screening small molecules targeting NR4A1 for therapeutic applications in cancer, inflammation, or metabolic diseases.
Overall, NR4A1 recombinant protein serves as a vital tool for unraveling its complex biology and developing targeted therapies.
×